Rezolute, Inc.

NASDAQ:RZLT

Biotechnology

Healthcare
$4.25 +6.16%

+$0.30 today

Market cap
$411.10M
Beta
0.65
P/E (TTM)
-6.5
EPS (TTM)
-$0.78
52W Low $1.07High $11.46

Volume 2.93M

Average 2.03M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$69.08M

FY 2025 · Annual

Investing Cash Flow

-$14.54M

FY 2025 · Annual

Financing Cash Flow

$107.33M

FY 2025 · Annual

+70.3% YoY

Cash Flow Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Net Income(20.9M)(41.06M)(51.79M)(68.46M)(74.41M)
Depreciation & Amortization13K13K30K36K31K
Deferred Income Tax(1.78M)0(1.37M)00
Stock-Based Compensation3.97M3.69M7.27M7.36M7.12M
Change in Working Capital(2.12M)(642K)1.02M3.1M47K
Accounts Receivables00000
Inventory00000
Accounts Payables142K(11K)2.14M1.08M1.42M
Other Working Capital(2.26M)(631K)(1.12M)2.02M(1.37M)
Other Non-Cash Items384K(1.61M)352K595K(1.86M)
Operating Cash Flow(20.44M)(39.62M)(44.48M)(57.37M)(69.08M)
Capital Expenditures00(153K)00
Acquisitions (Net)00101.46M00
Purchases of Investments00(107.31M)(66.4M)(128.14M)
Sales of Investments006M115.1M113.6M
Other Investing Activities00(101.46M)00
Investing Cash Flow00(101.46M)48.7M(14.54M)
Debt Repayment15M(16.01M)000
Common Stock Issued41M122.82M12.33M49.02M107.33M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(4.47M)31.39M(759K)14.01M0
Financing Cash Flow51.53M148.98M11.57M63.03M107.33M
Effect of Forex Changes00000
Net Change in Cash31.09M109.36M(134.37M)54.36M23.71M
Free Cash Flow(20.44M)(39.62M)(44.63M)(57.37M)(69.08M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$74.4M
+ D&A$31.0K
+ Stock-Based Comp$7.1M
+ Deferred Tax$0
+ Working Capital$47.0K
- Other Non-Cash-$1.9M
= Operating Cash Flow-$69.1M
- Capex$0
= Free Cash Flow-$69.1M

Analysis

FY2025 free cash flow is -$69.1M. FCF conversion is 92.8% of net income. Operating cash flow was -$69.1M, with capex of $0. The largest bridge item is Stock-Based Comp at $7.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
FWPFWP filingNov 13, 2026
SC 13G/ASC 13G/A filingNov 13, 2026
424B5424B5 filingNov 13, 2026
SC 13GSC 13G filingNov 13, 2026
8-KCurrent reportNov 13, 2026

Does RZLT generate free cash flow?

Rezolute, Inc. (RZLT) generated -$69.08M of free cash flow in fiscal 2025.

How much operating cash flow does RZLT produce?

Operating cash flow was -$69.08M, before capital expenditures of $0.00.